Lund University researchers have devised an immunoaffinity-based mass spec platform for discovery proteomics that they are developing for use in histological grading of tumors and have formed a company, Immunovia, to commercialize the technology.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In PNAS this week: peanut subgenome progenitor sequence, homozygosity mapping and linkage analyses using exome data, and more.
Tech companies like Microsoft are looking into DNA as a data storage device, Scientific American writes.
The New York Times writes that the Max Planck Institute for Infection Biology's Emmanuelle Charpentier has always been on the move, though now it's more about CRISPR.
The European Union calls for all publicly funded scientific papers to be immediately freely accessible to the public by 2020.